CELG-RI
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$0.12
+1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.02x
- P/E 2027E
- 0.02x
- P/E 2028E
- 0.02x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.03x
- PEG TTM
- 0.01x
- Price / book
- 0.01x
- Price / sales
- 0.00x
- Price / cash flow
- 0.02x
Enterprise value
- Enterprise value
- $36.2B
- EV / sales
- 0.75x
- EV / EBITDA
- 1.96x
- EV / EBIT
- 2.36x
- Market cap
- $241.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026